Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates
Pathogenic mycobacteria pose a sustained threat to global human health. Recently, cytochrome bcc complexes have gained interest as targets for antibiotic drug development. However, there is currently no structural information for the cytochrome bcc complex from these pathogenic mycobacteria. Here, w...
Main Authors: | Shan Zhou, Weiwei Wang, Xiaoting Zhou, Yuying Zhang, Yuezheng Lai, Yanting Tang, Jinxu Xu, Dongmei Li, Jianping Lin, Xiaolin Yang, Ting Ran, Hongming Chen, Luke W Guddat, Quan Wang, Yan Gao, Zihe Rao, Hongri Gong |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2021-11-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/69418 |
Similar Items
-
Telacebec : an investigational antibacterial for the treatment of tuberculosis (TB)
by: Lee, Bei Shi, et al.
Published: (2022) -
Response of <i>Mycobacterium smegmatis</i> to the Cytochrome <i>bcc</i> Inhibitor Q203
by: Priyanka Chauhan, et al.
Published: (2022-09-01) -
BCC and Childhood Low Dose Radiation
by: Arash Beiraghi Toosi, et al.
Published: (2014-10-01) -
Metastatic and locally aggressive BCC: Current treatment options
by: Máire‐Caitlín Casey, et al.
Published: (2021-10-01) -
Structure of mycobacterial CIII2CIV2 respiratory supercomplex bound to the tuberculosis drug candidate telacebec (Q203)
by: David J Yanofsky, et al.
Published: (2021-09-01)